Page 42 - Risk Evaluation News Today

As a Texas judge considers a case that could ban a drug used in medical abortion, Oregon's Attorney General seeks to reduce barriers to it

The federal government cannot compel pharmaceutical manufacturers to sell prescription drugs at a discount to unlimited numbers of pharmacies.  That is the takeaway from the Third...

With a history as a date rape drug, a medication needed strict distribution controls. Its maker, Jazz Pharmaceuticals, used that to delay competition.

Procedural History - Jazz Pharms., Inc., v. Avadel CNS Pharms., LLC, Case No. 2023-1186 (Fed. Cir. February 24, 2023) is an appeal by Jazz Pharmaceuticals, Inc. (Jazz)...

Jazz Pharmaceuticals, Inc. v. Avadel CNS Pharmaceuticals, LLC, Appeal No. 2023-1186 (Fed. Cir. Feb. 24, 2023) In this week’s Case of the Week, the Federal Circuit...

Democrats and Republicans are squaring off in dueling legal efforts in opposition and defense of the widely used ...

Crain's Health Pulse is your source for actionable, exclusive and inside news on the health care industry.

The suit comes as a federal judge in another case is considering whether to overturn FDA approval of the same drug, mifepristone.

A coalition of state attorneys general is suing the FDA over what they call excessive abortion pill rules on mifepristone.

Attorneys General of Oregon and Washington have filed lawsuits with other states against the FDA's regulation of the abortion drug mifepristone.